Free Biopharma Stock Content

Lot's of catalysts still coming Q1 2023, see more details and Catalyst Calendar below... 💬 Connect with us and fellow traders → in our...

Lot's of catalysts still coming in February, more details below... Last week hedge funds had to report their Q4 holdings, we analyzed 35+...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Originally posted 2/16/23; last updated 4/28/23 Summary: Many exciting eye disease catalysts are coming throughout the year See the table...

Last updated 4/26/23 Summary: Many exciting heart disease catalysts are coming throughout the year See the table below for some upcoming...

Last updated 4/25/23 Summary: Many exciting ovarian cancer catalysts are coming throughout the year See the table below for some upcoming...

Summary: Q4 2022 quarterly financial reports have started! Many large cap biotechs have already reported, and we expect most of the...

Summary: Many exciting mental health catalysts are coming throughout the year See the table below for some upcoming catalysts and sign up...

The ASCO-GU meeting mid Feb kicks off this week! Also have the PDUFA decision for $TVTX with a target date of Friday. See catalysts...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Last updated 4/21/23 Summary: Many exciting non-small cell lung cancer catalysts are coming throughout the year See the table below for...

Summary: Many exciting kidney disease catalysts are coming throughout the year See the table below for some upcoming catalysts and sign...

Summary: Many exciting colorectal cancer catalysts are coming throughout the year See the table below for some upcoming catalysts and...

Summary: Many exciting prostate cancer catalysts are coming throughout the year See the table below for some upcoming catalysts and sign...

Summary: ESPR first announced Clear Outcomes Nexletol data in Dec 2022, but only stated the primary endpoint was met They reported that...

Originally posted 2/6/2023; last updated 5/5/2023 Summary: Many exciting breast cancer catalysts are coming throughout the year See the...

Already a month into 2023 but still a lot of big events coming this quarter. We have a number of readouts coming including GTHX phase 3...

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Originally published 2/3/23; last updated 3/29/23 Summary: Many exciting liver disease catalysts are coming in the first quarter of the...

Summary: The CYTK PDUFA for Omecamtiv Mecarbil is coming up on February 28 for heart failure with reduced ejection fraction (HErEF) The...